|
USP46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1730174043787E-13 |
| Normal-vs-Stage2 |
4.14800000003712E-06 |
| Normal-vs-Stage3 |
5.96311888756418E-12 |
| Normal-vs-Stage4 |
6.06181771445335E-14 |
| Stage1-vs-Stage2 |
2.106800E-01 |
| Stage1-vs-Stage3 |
7.042000E-02 |
| Stage1-vs-Stage4 |
4.840400E-04 |
| Stage2-vs-Stage3 |
1.076270E-02 |
| Stage2-vs-Stage4 |
2.795700E-04 |
| Stage3-vs-Stage4 |
1.332420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09130490702591E-11 |
| Normal-vs-AfricanAmerican |
3.249100E-04 |
| Normal-vs-Asian |
6.8638983385938E-11 |
| Caucasian-vs-AfricanAmerican |
1.715150E-01 |
| Caucasian-vs-Asian |
5.597600E-01 |
| AfricanAmerican-vs-Asian |
1.475580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32702745961433E-13 |
| Normal-vs-Female |
1.62558855265615E-12 |
| Male-vs-Female |
4.066200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.49169573862673E-11 |
| Normal-vs-Age(41-60Yrs) |
2.77555756156289E-15 |
| Normal-vs-Age(61-80Yrs) |
1.13939968571231E-11 |
| Normal-vs-Age(81-100Yrs) |
1.336920E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.740000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.471800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.327400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.411200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.726000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.780400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.692410E-02 |
| Classical-VS-Follicular |
2.619700E-03 |
| Classical-VS-Other |
5.618800E-01 |
| Classical-VS-Normal |
1.10329967384359E-10 |
| Tall-VS-Follicular |
4.19409999999898E-05 |
| Tall-VS-Other |
6.560000E-01 |
| Tall-VS-Normal |
3.46056516775661E-12 |
| Follicular-VS-Other |
1.595230E-01 |
| Follicular-VS-Normal |
3.79010000000068E-05 |
| Other-VS-Normal |
1.404680E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.76156916515447E-12 |
| Normal-vs-N1 |
1.23456800338317E-13 |
| N0-vs-N1 |
8.635200E-04 |
|
|
